(Q50593889)

English

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

0 references

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Laffel LM

1

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

McGill JB

2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

Gans DJ

3

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

language of work or name

0 references

publication date

1 November 1995

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

99

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

497-504

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Incipient nephropathy in type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Microalbuminuria as a predictor of clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Renal Factors Influencing Blood Pressure Threshold and Choice of Treatment for Hypertension in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Renal protective effect of enalapril in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Blood glucose control determines the renal haemodynamic response to angiotensin converting enzyme inhibition in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Diabetic renal disease: the quest for normotension--and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

The predictive value of microalbuminuria in IDDM. A five-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980226-5

7 January 2021

Identifiers

10.1016/S0002-9343(99)80226-5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/7485207

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50593889&oldid=2254052201"